Press Releases

PetMedix raises $37M Series B

PetMedix™ announces the completion of an oversubscribed $37M (£27M) Series B financing round that will be used to advance its innovative pipeline through clinical development.

Read More »

PetMedix win Best Start-up 2019 in the Animal Pharm Awards

PetMedix has been voted best start-up in the global Animal Pharm Awards. The UK-based start-up is developing a new tier of monoclonal antibody therapy for the animal health market. Situated in the heart of the Cambridge biotechnology cluster, 2020 will see the company take up residence in the new Babraham Campus later in the year.

Read More »
Scroll to Top